Biocompatible Amino-modificated Tantalum Nanoparticles with Catalase Activity for Sustained Intra-articular Reactive Oxygen Species Scavenging and Alleviation of MIA Induced Osteoarthritis

Yunsheng Jiang,Tao Li,Junjun Yang,Xin Wang,Xiongbo Song,GuangXing Chen,Gang Dai,Rong Li,Chunyan Yao,Jiajia Chen,Xiaoyuan Gong,Liu Yang
DOI: https://doi.org/10.21203/rs.3.rs-1988275/v1
2022-01-01
Abstract:Background Osteoarthritis (OA), which involves the dysfunction of articular cartilage, is the most common form of joint disease that results in arthralgia, joint deformation and limited mobility in patients. Recent studies highlighted the vital role of oxidative stress and reactive oxygen species (ROS) during progression of OA. Therefore, attenuating oxidative stress and reducing ROS generation in articular joints represent reasonable strategies for the treatment of OA. However, in addition to instability of current antioxidants caused by fluctuation in osteoarthritic physicochemical microenvironment, poor biocompatibility and short articular joint retention also seriously hindered their clinical application. Results Considering the above-mentioned, the present study provided high biocompatible small positively charged tantalum nanoparticles (Ta-NH 2 NPs) with sustained intra-articular catalase activity. Our in vitro results showed that Ta-NH 2 NPs had good biocompatibility and stability, and could protect viability and hyaline-like phenotype in chondrocyte under H 2 O 2 challenge. In addition, the in vivo biodistribution data demonstrated sustained retention of Ta-NH 2 NPs in the joint cavity, particularly in articular cartilage with unnoticed organ toxicity and abnormity in hemogram and blood biochemistry analyses. Finally, compared with catalase (CAT), Ta-NH 2 NPs exhibited long-term therapeutic effect in monosodium iodoacetate (MIA) induced OA model. Conclusion This study explored the potential of Ta-NH 2 NPs as effective ROS scavenging agent for intra-articular injection, and offered a novel strategy to achieve sustained ROS suppression using biocompatible Ta-based nano-medicine in oxidative stress related diseases.
What problem does this paper attempt to address?